Patient advocacy may still be in its early stages, but it has the potential to change the role of the patient in healthcare. What is patient advocacy, and how might it change the way we view patients? In today's episode, Darshan Kulkarni talks with...
Not all products have to meet the U.S. Federal Drug Administration’s (FDA) approval: certain biologics and dietary supplements do not require it, and there are alternative pathways for OTC drugs and other products to skip the process.
The US Food and Drug Administration (FDA) issued a warning letter to stem cell clinics about releasing unproven treatments which posed high health risks to patients.
Bioethics is the application of ethics to the field of life sciences and health—it determines what constitutes an ethical approach in the world of clinical trials and research on hot button issues like eugenics, gene-editing, and the right to die...
23andMe as well as other spit-in-a-tube genetics companies have been profiting off of selling consumers’ genetic data to drugmakers, but recently, 23andMe took a more explicit step when they partnered with drug giant GlaxoSmithKline. 23andMe...
The FDA recently went after VIVUS, a pharmaceutical company, for making false health claims about its product. Inappropriate drug promotions can pose serious issues for pharmaceutical companies that go beyond superficial penalties--companies can...
